Skip to content

Computerized cognitive training and whole-body cryotherapy and health-related psychological factors in seniors

Synergetic effects of computerized cognitive training and whole-body cryotherapy – a controlled pre-post study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN97862537
Enrollment
111
Registered
2022-09-06
Start date
2018-08-01
Completion date
Unknown
Last updated
2022-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of dementia in older adults (aged 65+ years) Mental and Behavioural Disorders Unspecified dementia

Interventions

A prospective, pre/post controlled, single-blind trial, parallel-group study is conducted. The study is not randomized due to the fact that the participants voluntarily agree to participate in one of

Sponsors

Wroclaw Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Written informed consent 2. Age =65 years 3. Cognitively healthy volunteers and with mild cognitive impairment (MCI) (scores in the Montreal Cognitive Assessment Scale (MoCa), score range: 0-30, cut-off points for norm: >26, 26-30 for MCI) 4. Basic computer knowledge

Exclusion criteria

Exclusion criteria: 1. Inability to understand questions and written information (presence of any type of severe visual, hearing or motor deficits) 2. Any psychiatric or neurological diagnosis (alcohol and drug abuse, psychosis, suicidal thoughts) 3. Standard contraindications to WBC

Design outcomes

Primary

MeasureTime frame
1. Level of dispositional optimism, defined as generalized expectations of positive events measured using the Revised Life Orientation Test (LOT-R) at T1: before intervention (CCT) or (CCT+WBC), T2: 9 weeks (immediately after intervention) 2. Level of sense of self-efficacy, defined as successful coping, adaptation to stressful events in life measured using the General Self-Efficacy Scale – Schwarzer (GSES) at T1: before intervention (CCT) or (CCT+WBC), T2: 9 weeks (immediately after intervention) 3. Level of cognitive judgments of life satisfaction, defined as subjective well-being and satisfactory quality of life measured with the Satisfaction With Life Scale (SWLS) at T1: before intervention (CCT) or (CCT+WBC), T2: 9 weeks (immediately after intervention) 4. Mood and degree of depressive symptoms measured using Geriatric Depression Scale (GDS-30) at T1: before intervention (CCT) or (CCT+WBC), T2: 9 weeks (immediately after intervention)

Secondary

MeasureTime frame
Cognitive status assessed using Montreal Cognitive Assessment (MoCA) test at T1: before intervention (CCT) or (CCT+WBC), T2: 9 weeks (immediately after intervention)

Countries

Poland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026